SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: phoenix_rising who wrote (1633)1/13/2016 8:31:37 PM
From: Mirror Image  Read Replies (1) of 2026
 
Who would have thought that the BIG lot of 450,000 shares sitting at .99 a few days ago would benefit Sarissa? BTW, they were prevented to buy or sell ( including short sell ) on the open market at that time.

By law, it could not have been them or anybody with knowledge of the deal.

5.4 Since December 1, 2015, representing the date at which the Company first contacted such Investor about the Offering, such Investor has not disclosed any information regarding the Offering to any third parties (other than its employees or the employees of its affiliates or their respective legal, accounting and other advisors) and has not engaged in any purchases or sales of the securities of the Company (including, without limitation, any Short Sales (as defined herein) involving the Company’s securities). Such Investor covenants that it will not engage in any purchases or sales of the securities of the Company (including Short Sales), other than the purchases of the Shares and the Warrants as contemplated hereby, prior to the time that the transactions contemplated by this Agreement are publicly disclosed (it being understood and agreed that such transactions shall be publicly disclosed no later than one business day following the execution of this Agreement by all parties hereto). Such Investor agrees that it will not use any of the Securities acquired pursuant to this Agreement to cover any short position in the Common Stock if doing so would be in violation of applicable securities laws. For purposes hereof, “Short Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against the box, and all types of direct and indirect stock pledges, forward sales contracts, options, puts, calls, short sales, swaps, “put equivalent positions” (as defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements (including on a total return basis), and sales and other transactions through non-U.S. broker dealers or foreign regulated brokers.
And with this last Purchase - If we thought Sarissa had much to lose if the Shares of Apricus became delisted, now they would have nothing to win if that happens ( on top of the loss ).

I know that .88 per share blows. But at least it's not a Secondary Offering. It's a Direct Offering and we at least have ONE of those that we can look back and look how we did historically after it. I have been here for at least 3 Secondary Offerings ( if not 4 with this company ) and I only know of ONE that the share price increased over the Offering price. The last Direct Offering that we had saw the stock price increase 50% above the Offering Price ( and NO, $1.32 doesn't cut it for me either ).

BTW, the share price closed at $1.10 on December 01, 2015.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext